Adult blood lead epidemiology and surveillance - United States, Second Quarter, 1997.
Lofgren-JP; Schaller-K; Payne-S; Jung-BC; Gergely-R; Hawkes-A; Keyvan-Larijani-E; Rabin-R; Scoblic-R; Falken-M; Thisle-Elliott-L; Gerwel-B; Prophet-R; Stone-R; Randolph-S; Migliozzi-A; Rhoades-E; Sandoval-A; Gostin-J; Stoeckel-M; Gardner-Hillian-A; Schnitzer-P; Ball-W; Toof-L; Kaufman-J; Tierney-J; Klietz-T
MMWR 1997 Oct; 46(42):1000-1002
CDC's National Institute for Occupational Safety and Health (NIOSH) Adult Blood Lead Epidemiology and Surveillance (ABLES) program monitors laboratory-reported elevated blood lead levels (BLLs) among adults in the United States. During 1997, a total of 27 states reported surveillance data to ABLES. In this report, ABLES data for the first and second quarters of 1997 are presented and compared with the first and second quarters of 1996. During April-June 1996 and 1997, reports of BLLs greater than or equal to 25 ug/dL by the same 27 states increased by 5%, from 5867 to 6157, respectively (1). This quarterly increase follows an increase of 13% during the first quarter of 1997 (2). The combined increase for the first two quarters of 1997 is 9% (Table-1); in comparison, the long-term trend had been decreasing during 1993-1996 (2-4) as had the overall number of reported BLLs greater than or equal to 25 ug/dL among adults in the United States (5).
Lead-absorption; Lead-compounds; Lead-dust; Blood-analysis; Blood-sampling; Central-nervous-system-disorders; Blood-disorders; Reproductive-system-disorders; Cardiovascular-system-disorders; Kidney-disorders; Environmental-exposure; Exposure-levels; Exposure-limits; Neurotoxic-effects; Surveillance-programs; Region-1; Region-10; Region-2; Region-3; Region-4; Region-5; Region-6; Region-7; Region-8; Region-9
Morbidity and Mortality Weekly Report
AL; CA; CT; IA; MA; MD; ME; MN; MI; NH; NJ; NM